Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Among“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · Among patients who experienced peripheral neuropathy in the pivotal phase 2 studies (SG035-0003 and SG035-0004
Eintrag öffnenAdcetris · 4.8 · Among patients who experienced peripheral neuropathy, the median follow up time from end of treatment until la
Eintrag öffnenAdcetris · 4.8 · Among patients who experienced peripheral neuropathy, the median follow up time from end of treatment until la
Eintrag öffnenAfqlir · 4.8 · A total of 3 102 patients constituted the safety population in the eight phase III studies. Among those, 2 501
Eintrag öffnenAfqlir · 4.8 · A total of 3 102 patients constituted the safety population in the eight phase III studies. Among those, 2 501
Eintrag öffnenAhzantive · 4.8 · A total of 3,102 patients constituted the safety population in the eight phase III studies. Among those, 2,501
Eintrag öffnenAhzantive · 4.8 · A total of 3,102 patients constituted the safety population in the eight phase III studies. Among those, 2,501
Eintrag öffnenAmgevita · 4.8 · 21 (95% confidence interval) of lymphomas was 0.7 (0.2, 2.7) per 1,000 patient-years among adalimumab-treated
Eintrag öffnenAmsparity · 4.8 · 105 non-melanoma skin cancers was 8.8 (6.0, 13.0) per 1,000 patient-years among adalimumab-treated patients an
Eintrag öffnenAptivus · 4.8 · Summary of the safety profile Amongst the most common adverse reactions reported for Aptivus were gastrointest
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.8 · Among patients who received atazanavir 400 mg once daily or atazanavir 300 mg with ritonavir 100 mg once daily
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.8 · Other special populations 31 Patients co-infected with hepatitis B and/or hepatitis C virus Among 1,151 patien
Eintrag öffnenAucatzyl · 4.8 · Among the safety set (N=127), median time from day of Aucatzyl infusion to neutrophil recovery to ≥ 0.5 × 109/
Eintrag öffnenAugtyro · 4.8 · 12 Hepatotoxicity Among the 565 patients treated with AUGTYRO, increased alanine transaminase (ALT) occurred i
Eintrag öffnenAugtyro · 4.8 · Dizziness Among the 565 adult patients who received at least one dose of AUGTYRO in TRIDENT-1, dizziness (incl
Eintrag öffnenAugtyro · 4.8 · Dyspnoea Among the 565 patients treated with AUGTYRO, dyspnoea occurred in 31.3% (177/565) of patients, with G
Eintrag öffnenAugtyro · 4.8 · ILD/pneumonitis Among the 565 patients treated with AUGTYRO, ILD/pneumonitis was reported in 3.2% (18/565) of
Eintrag öffnenAugtyro · 4.8 · Vision disorder Among the 565 patients who received AUGTYRO, vision changes occurred in 14.2 % (80/565) of pat
Eintrag öffnenAyvakyt · 4.8 · Most cognitive effects were Grade 1, with Grade ≥2 occurring in 11% of 550 patients. Among patients who experi
Eintrag öffnenBaiama · 4.8 · A total of 3,102 patients constituted the safety population in the eight phase III studies. Among those, 2,501
Eintrag öffnen